Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2650-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2261-126 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L71-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L101-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
filingDate |
2003-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-100933580-B1 |
titleOfInvention |
Biodegradable Block Copolymerizable Compositions for Drug Delivery |
abstract |
Improved drug delivery compositions and their use are disclosed. The composition comprises one or more biodegradable block copolymer drug carriers comprising polyethylene glycol (PEG), PEG derivatives or a mixture of PEG and PEG derivatives; Contains reconstitution enhancers and possible agents. The composition can be administered intact or after dissolution or rapid reconstitution in an aqueous vehicle that allows for a homogeneous solution or a uniform colloidal system.n n n Drug delivery composition |
priorityDate |
2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |